Description:SR3335, with the CAS number 293753-05-6, is a chemical compound that functions primarily as a selective modulator of the nuclear receptor peroxisome proliferator-activated receptor gamma (PPARγ). This compound is notable for its potential therapeutic applications, particularly in the treatment of metabolic disorders such as obesity and type 2 diabetes. SR3335 exhibits characteristics that allow it to selectively activate PPARγ, which plays a crucial role in regulating glucose metabolism and adipocyte differentiation. The compound is typically studied in the context of its pharmacological effects, including its ability to improve insulin sensitivity and alter lipid metabolism. Additionally, SR3335 is characterized by its specific binding affinity to PPARγ, which distinguishes it from other compounds that may have broader or less selective effects on nuclear receptors. As research continues, the full spectrum of its biological activities and potential side effects is being explored, contributing to the understanding of its role in metabolic regulation and potential clinical applications.
N-[4-[2,2,2-Trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-2-thiophenesulfonamide is a versatile compound with various applications. It can be used as an anticoagulant, …
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.